Breast Cancer Treatment Based on Organ-like Culture
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Trastuzumab
Related studies linked through entity extraction aliases.
Pyrotinib Combined With Trastuzumab and AI in the First-line Treatment of HER2 Positive/ HR Positive MBC
- Status
- UNKNOWN
- Phase
- PHASE2
Improving Pre-operative Systemic Therapy for Human Epidermal Growth Factor Receptor 2 (HER2) Amplified Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Tucatinib + Abemaciclib + Herceptin for HER2+ MBC
- Status
- WITHDRAWN
- Phase
- PHASE1
Durvalumab With Trastuzumab and Pertuzumab in HER2-Enriched Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Compare Pertuzumab + Trastuzumab + Vinorelbine vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE3
Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas
- Status
- COMPLETED
- Phase
- PHASE2
MEN1611 With Trastuzumab (+/- Fulvestrant) in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Trastuzumab Beyond Progression in HER2 Positive Metastatic Gastric Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases
- Status
- TERMINATED
- Phase
- PHASE2
Neoadjuvant Study of Pyrotinib in Patients With HER2 Positive Breast Cancer
- Status
- UNKNOWN
- Phase
- NA
Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Multiparametric MRI for Assessing Breast Cancer Response to Anti-HER2 Therapy
- Status
- TERMINATED
- Phase
- N/A
A Study To Evaluate the Efficacy and Safety Of Atezolizumab or Placebo in Combination With Neoadjuvant Doxorubicin + Cyclophosphamide Followed By Paclitaxel + Trastuzumab + Pertuzumab In Early Her2-Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
DAPHNe: Paclitaxel/Trastuzumab/Pertuzumab in HER2-Positive BC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of ACTR T Cell Product in Combination With Trastuzumab in Subjects With HER2-Positive Advanced Solid Tumor Cancers
- Status
- TERMINATED
- Phase
- PHASE1
To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH)
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab/Placebo Plus Trastuzumab Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-811/KEYNOTE-811)
- Status
- COMPLETED
- Phase
- PHASE3
Trastuzumab in HER2-positive Biliary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3